The report provides analysis and forecast for the respiratory disease testing market on a regional and global level. The study covers historic data of 2015 provided along with a forecast from 2016 to 2021 based on revenue (USD billion). The study provides restraints and drivers for the respiratory disease testing market coupled along with the impact they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities present in the respiratory disease testing market on a global level.
With the objective to give the users of this report a complete and clear view on the respiratory disease testing market and to better understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the respiratory disease testing market has also been covered. The study provides with a comprehensive market attractiveness analysis, wherein product segments and end-user segments are based on their growth rate, market size, and general attractiveness.
The study provides a clear view on the respiratory disease testing market by segmenting the market based on end-user segment, product segment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the respiratory disease testing market has been segmented into imaging, spirometry, peak flow, blood gas, lung volume, and other tests. Based on the end-user segment, the respiratory disease testing market has been segmented into physician offices, hospitals, and clinical laboratories. The regional segmentation includes the current and forecast demand for Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa with its further bifurcation into major countries including Germany, France, UK, China, Japan, India, U.S. AND Brazil.
The report also includes comprehensive profiles of end players such as ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. GE Healthcare and others. The thorough description of players includes parameters such as company overview, business, financial overview, and recent developments of the company.
This report segments the global respiratory disease testing market as follows:
Global Respiratory Disease Testing Market: Product Segment Analysis
- Lung Volume
- Imaging
- Spirometry
- Peak Flow
- Blood Gas
- Other Tests
Global Respiratory Disease Testing Market: End-user Segment Analysis
- Hospitals
- Physician Offices
- Clinical Laboratories
Global Respiratory Disease Testing Market: Regional Segment Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Respiratory Disease Testing market, 2015 - 2021 (USD Billion)
- 2.2. Global Respiratory Disease Testing market: Snapshot
- Chapter 3. Respiratory Disease Testing – Market Dynamics
- 3.1. Introduction
- 3.2. Value chain analysis
- 3.3. Market drivers
- 3.3.1. Increase in Prevalence of Respiratory Diseases
- 3.3.2. Changing Lifestyle and Improvement in Medical Facilities
- 3.4. Market restraints
- 3.4.1. Low adoption rate of advanced spirometers and digital radiography systems
- 3.5. Opportunities
- 3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific
- 3.6. Porter’s five forces analysis
- 3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers
- 3.6.3. Threat from new entrants
- 3.6.4. Threat from new substitutes
- 3.6.5. Degree of competition
- 3.7. Market attractiveness analysis
- 3.7.1. Market attractiveness analysis, by product segment
- 3.7.2. Market attractiveness analysis, by end-user segment
- 3.7.3. Market attractiveness analysis, by regional segment
- Chapter 4. Global Respiratory Disease Testing Market – Competitive Landscape
- 4.1. Company market share, 2015 (Subject to data availability)
- 4.2. Price trend analysis
- Chapter 5. Global Respiratory Disease Testing Market – Product Segment Analysis
- 5.1. Global Respiratory Disease Testing market: Product segment overview
- 5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021
- 5.2. Lung Volume
- 5.2.1. Global Lung Volume market , 2015 – 2021 (USD Billion)
- 5.3. Imaging
- 5.3.1. Global Imaging market, 2015 – 2021 (USD Billion)
- 5.4. Spirometry
- 5.4.1. Global Spirometry market, 2015 – 2021 (USD Billion)
- 5.5. Peak Flow
- 5.5.1. Global Peak Flow market, 2015 – 2021 (USD Billion)
- 5.6. Blood Gas
- 5.6.1. Global Blood Gas market, 2015 – 2021 (USD Billion)
- 5.7. Others
- 5.7.1. Global Other Tests market, 2015 – 2021 (USD Billion)
- Chapter 6. Global Respiratory Disease Testing Market – End-user Segment Analysis
- 6.1. Global Respiratory Disease Testing market: End-user segment overview
- 6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021
- 6.2. Hospitals
- 6.2.1. Global Hospitals market , 2015 – 2021 (USD Billion)
- 6.3. Physician Offices
- 6.3.1. Global Physician Offices market, 2015 – 2021 (USD Billion)
- 6.4. Clinical Laboratories
- 6.4.1. Global Clinical Laboratories market, 2015 – 2021 (USD Billion)
- Chapter 7. Global Respiratory Disease Testing Market – Regional Segment Analysis
- 7.1. Global Respiratory Disease Testing Market: Regional Overview
- 7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021
- 7.2. North America
- 7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
- 7.2.3. U.S.
- 7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.3. Europe
- 7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.3.3. UK
- 7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.3.4. France
- 7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
- 7.3.5. Germany
- 7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.4.3. China
- 7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.4.4. Japan
- 7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.4.5. India
- 7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.5.3. Brazil
- 7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- 7.6. Middle East And Africa
- 7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
- 7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
- Chapter 8. Company Profile
- 8.1. ndd Medical Technologies, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Carestream Health, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. SDI Diagnostics
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Nihon Kohden Corporation
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. CareFusion Corporation
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Developments
- 8.6. Smiths Medical
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Developments
- 8.7. COSMED
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Developments
- 8.8. Perkin Elmer, Inc.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Developments
- 8.9. Philips Healthcare
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Developments
- 8.10. MGC Diagnostic Corporation
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Developments
- 8.11. Futuremed America, Inc.
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategy
- 8.11.5. Recent Developments
- 8.12. GE Healthcare
- 8.12.1. Overview
- 8.12.2. Financials
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategy
- 8.12.5. Recent Developments